Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacqueline M Lafky

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Trends in Cell Biology|April 30, 2002
Receptor tails and transcriptional regulationNita J Maihle, Jacqueline M Lafky
Methods in Molecular Biology (Clifton, N.J.)|June 20, 2006
Soluble epidermal growth factor receptor acridinium-linked immunosorbent assayJacqueline M Lafky, Andre T Baron, Nita J Maihle
Biochimica Et Biophysica Acta|February 23, 2008
Clinical implications of the ErbB/epidermal growth factor (EGF) receptor family and its ligands in ovarian cancerJacqueline M Lafky, Jason A Wilken, Andre T Baron, et al.
JAMA Oncology|December 27, 2019
Clinician vs Patient Reporting of Baseline and Postbaseline Symptoms for Adverse Event Assessment in Cancer Clinical TrialsThomas M Atkinson, Amylou C Dueck, Daniel V Satele, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 17, 2023
A pilot randomized, placebo-controlled, double-blind study of omega-3 fatty acids to prevent paclitaxel-associated acute pain syndrome in breast cancer patients: Alliance A22_Pilot2Bernard Tawfik, Zoneddy R Dayao, Ursa Abigail Brown-Glaberman, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 1, 2005
Soluble epidermal growth factor receptor (sEGFR) [corrected] and cancer antigen 125 (CA125) as screening and diagnostic tests for epithelial ovarian cancerAndre T Baron, Cecelia H Boardman, Jacqueline M Lafky, et al.
Cancer Research|April 19, 2005
Serum soluble epidermal growth factor receptor concentrations decrease in postmenopausal metastatic breast cancer patients treated with letrozoleJacqueline M Lafky, Andre T Baron, Elsa M Cora, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 8, 2015
MC11C4: a pilot randomized, placebo-controlled, double-blind study of venlafaxine to prevent oxaliplatin-induced neuropathyCollin Zimmerman, Pamela J Atherton, Deirdre Pachman, et al.
Journal of Geriatric Oncology|December 14, 2017
The impact of actual body weight-based chemotherapy dosing and body size on adverse events and outcome in older patients with breast cancer: Results from Cancer and Leukemia Group B (CALGB) trial 49907 (Alliance A151436)Vicki A Morrison, Linda McCall, Hyman B Muss, et al.
The Oncologist|April 21, 2018
Promoting Accrual of Older Patients with Cancer to Clinical Trials: An Alliance for Clinical Trials in Oncology Member Survey (A171602)Rachel A Freedman, Travis J Dockter, Jacqueline M Lafky, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Trends in Cell Biology|April 30, 2002
Receptor tails and transcriptional regulationNita J Maihle, Jacqueline M Lafky
Methods in Molecular Biology (Clifton, N.J.)|June 20, 2006
Soluble epidermal growth factor receptor acridinium-linked immunosorbent assayJacqueline M Lafky, Andre T Baron, Nita J Maihle
Biochimica Et Biophysica Acta|February 23, 2008
Clinical implications of the ErbB/epidermal growth factor (EGF) receptor family and its ligands in ovarian cancerJacqueline M Lafky, Jason A Wilken, Andre T Baron, et al.
JAMA Oncology|December 27, 2019
Clinician vs Patient Reporting of Baseline and Postbaseline Symptoms for Adverse Event Assessment in Cancer Clinical TrialsThomas M Atkinson, Amylou C Dueck, Daniel V Satele, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 17, 2023
A pilot randomized, placebo-controlled, double-blind study of omega-3 fatty acids to prevent paclitaxel-associated acute pain syndrome in breast cancer patients: Alliance A22_Pilot2Bernard Tawfik, Zoneddy R Dayao, Ursa Abigail Brown-Glaberman, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 1, 2005
Soluble epidermal growth factor receptor (sEGFR) [corrected] and cancer antigen 125 (CA125) as screening and diagnostic tests for epithelial ovarian cancerAndre T Baron, Cecelia H Boardman, Jacqueline M Lafky, et al.
Cancer Research|April 19, 2005
Serum soluble epidermal growth factor receptor concentrations decrease in postmenopausal metastatic breast cancer patients treated with letrozoleJacqueline M Lafky, Andre T Baron, Elsa M Cora, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 8, 2015
MC11C4: a pilot randomized, placebo-controlled, double-blind study of venlafaxine to prevent oxaliplatin-induced neuropathyCollin Zimmerman, Pamela J Atherton, Deirdre Pachman, et al.
Journal of Geriatric Oncology|December 14, 2017
The impact of actual body weight-based chemotherapy dosing and body size on adverse events and outcome in older patients with breast cancer: Results from Cancer and Leukemia Group B (CALGB) trial 49907 (Alliance A151436)Vicki A Morrison, Linda McCall, Hyman B Muss, et al.
The Oncologist|April 21, 2018
Promoting Accrual of Older Patients with Cancer to Clinical Trials: An Alliance for Clinical Trials in Oncology Member Survey (A171602)Rachel A Freedman, Travis J Dockter, Jacqueline M Lafky, et al.
Pageof 5